WALTHAM, Mass., Dec. 7, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B). The dividend is payable on January 15, 2013 to holders of record of Series B stock at the close of business on January 2, 2013. Such payment will cover the amount of all dividends accrued from October 1, 2012 through December 31, 2012. For more information about Alere, please visit our website at http://www.alere.com. By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on cardiology, infectious disease, toxicology, diabetes, oncology and women's health. Alere is headquartered in Waltham, Massachusetts. SOURCE Alere Inc.